Galectin Therapeutics
(NASDAQ) GALT
Galectin Therapeutics Financials at a Glance
Market Cap
$172.16M
Revenue (TTM)
$0.00
Net Income (TTM)
$30.84M
EPS (TTM)
$-0.48
P/E Ratio
-5.51
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$2.68
Volume
7,705
Open
$2.66
Price
$2.68
Volume
7,705
Open
$2.66
Previous Close
$2.68
Daily Range
$2.55 - $2.69
52-Week Range
$1.12 - $7.13
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$2.68
Volume
7,705
Open
$2.66
Previous Close
$2.68
Daily Range
$2.55 - $2.69
52-Week Range
$1.12 - $7.13
GALT News
GALT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Galectin Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Joel Lewis, CPA
Website
www.galectintherapeutics.comHeadquarters
Norcross, GA 30071, US
GALT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-18.15%
Dividend Yield
0.00%
Payout Ratio
-0.20%
Stock Overview
Market Cap
$172.16M
Shares Outstanding
64.48M
Volume
7.71K
Short Interest
0.00%
Avg. Volume
340.99K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$20.09M
EBITDA
$23.45M
Operating Cash Flow
$23.88M
Capital Expenditure
$0.00
Free Cash Flow
$23.88M
Cash & ST Invst.
$17.72M
Total Debt
$133.74M
Galectin Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$12.00K
+220.0%
Gross Margin
0.00%
N/A
Market Cap
$172.16M
N/A
Market Cap/Employee
$11.48M
N/A
Employees
15
N/A
Net Income
$5.50M
+54.0%
EBITDA
$19.93M
+294.8%
Quarterly Fundamentals
Net Cash
$116.02M
-27.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$133.74M
+57.1%
Short Term Debt
$22.00K
-99.9%
Return on Assets
-1.58%
N/A
Return on Invested Capital
-1.75%
N/A
Free Cash Flow
$6.04M
+52.8%
Operating Cash Flow
$6.04M
+52.8%